433 related articles for article (PubMed ID: 17460837)
21. Antibiotic Resistance of Viridans Group Streptococci Isolated from Dental Plaques.
Kim YH; Lee SY
Biocontrol Sci; 2020; 25(3):173-178. PubMed ID: 32938847
[TBL] [Abstract][Full Text] [Related]
22. Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis.
Streit JM; Steenbergen JN; Thorne GM; Alder J; Jones RN
J Antimicrob Chemother; 2005 Apr; 55(4):574-8. PubMed ID: 15722390
[TBL] [Abstract][Full Text] [Related]
23. Tigecycline (GAR-936) activity against Streptococcus gallolyticus (bovis) and viridans group streptococci.
Moet GJ; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):333-6. PubMed ID: 16989974
[TBL] [Abstract][Full Text] [Related]
24. [Identification and antibiotic susceptibility of viridans group streptococci isolates recovered from patients hospitalized at a teaching hospital in Buenos Aires City].
Heine AC; García S; Barberis C; Vay C; E Mollerach M; Bonofiglio L; Famiglietti Á
Rev Argent Microbiol; 2019; 51(1):26-31. PubMed ID: 29941157
[TBL] [Abstract][Full Text] [Related]
25. [Susceptibility to penicillin and 13 antimicrobial agents in erythromycin-resistant viridans group streptococci isolated from blood cultures].
Rodríguez-Avial C; Rodríguez-Avial I; Picazo JJ
Rev Esp Quimioter; 2001 Sep; 14(3):275-80. PubMed ID: 11753449
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial resistance of community-acquired bloodstream isolates of viridans group streptococci.
Yap RL; Mermel LA; Maglio J
Infection; 2006 Dec; 34(6):339-41. PubMed ID: 17180589
[TBL] [Abstract][Full Text] [Related]
27. Prospective national survey of viridans streptococcal bacteraemia risk factors, antibacterial susceptibility and outcome of 120 episodes.
Mrazova M; Docze A; Buckova E; Bucko L; Kacmarikova M; Grey E; Korcova J; Koprnova J; Saboova Z; Beno P; Karvaj M; Svetlansky I; Ondrus A; Benca J; Taziarova M; Rudinsky B; Krcmery V
Scand J Infect Dis; 2005; 37(9):637-41. PubMed ID: 16126562
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.
Huang WT; Chang LY; Hsueh PR; Lu CY; Shao PL; Huang FY; Lee PI; Chen CM; Lee CY; Huang LM
J Microbiol Immunol Infect; 2007 Aug; 40(4):349-54. PubMed ID: 17712470
[TBL] [Abstract][Full Text] [Related]
29. In vitro activity of moxifloxacin compared to other antimicrobials against streptococci isolated from iatrogenic oral bacteremia in Spain.
Tomás I; Alvarez M; Limeres J; Otero JL; Saavedra E; López-Meléndez C; Diz P
Oral Microbiol Immunol; 2004 Oct; 19(5):331-5. PubMed ID: 15327647
[TBL] [Abstract][Full Text] [Related]
30. Comparison of minimum inhibitory concentration by broth microdilution testing versus standard disc diffusion testing in the detection of penicillin, erythromycin and ciprofloxacin resistance in viridans group streptococci.
Maeda Y; Goldsmith CE; Coulter WA; Mason C; Dooley JSG; Lowery CJ; Millar BC; Moore JE
J Med Microbiol; 2011 Dec; 60(Pt 12):1782-1786. PubMed ID: 21852527
[TBL] [Abstract][Full Text] [Related]
31. Characterisation of viridans group streptococci with different levels of Tet(M)-mediated tetracycline resistance.
Stapleton P; Adams V; Pike R; Lucas V; Roberts G; Mullany P; Rowbury R; Wilson M; Richards H
Int J Antimicrob Agents; 2004 Nov; 24(5):439-43. PubMed ID: 15519474
[TBL] [Abstract][Full Text] [Related]
32. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood].
Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ
Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014
[TBL] [Abstract][Full Text] [Related]
33. Comparison of antibiotic susceptibility in viridans group streptococci in low and high antibiotic-prescribing General Practices.
Goldsmith CE; Hara Y; Sato T; Nakajima T; Nakanishi S; Mason C; Moore JE; Matsuda M; Coulter WA
J Clin Pharm Ther; 2015 Apr; 40(2):204-7. PubMed ID: 25604860
[TBL] [Abstract][Full Text] [Related]
34. UV-C-irradiation sublethal stress does not alter antibiotic susceptibility of the viridans group streptococci to β-lactam, macrolide, and fluoroquinolone antibiotic agents.
Maeda Y; Coulter WA; Goldsmith CE; Cherie Millar B; Moore JE
J Investig Clin Dent; 2012 Aug; 3(3):198-202. PubMed ID: 22887906
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibility of Viridians Group of Streptococci isolated from infective endocarditis patients from 2018 to 2023.
Jagadeesan N; Karur K; Nandini MP; Manjunath CN; Prapulla Kumari N; Praveen Kumar HD
Indian J Med Microbiol; 2024; 49():100576. PubMed ID: 38556250
[TBL] [Abstract][Full Text] [Related]
36. Viridans streptococci isolated by culture from blood of cancer patients: clinical and microbiologic analysis of 50 cases.
Han XY; Kamana M; Rolston KV
J Clin Microbiol; 2006 Jan; 44(1):160-5. PubMed ID: 16390964
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial resistance of Staphylococcus aureus and oral streptococci strains from high-risk endocarditis patients.
Groppo FC; Castro FM; Pacheco AB; Motta RH; Filho TR; Ramacciato JC; Florio FM; Meechan JG
Gen Dent; 2005; 53(6):410-3. PubMed ID: 16366048
[TBL] [Abstract][Full Text] [Related]
38. [Viridans streptococci in human infections: identification and susceptibility to antibiotics].
Horodniceanu T; Delbos F
Ann Microbiol (Paris); 1982; 133(2):255-69. PubMed ID: 7149526
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial susceptibility of viridans group streptococcal blood isolates to eight antimicrobial agents.
Smith A; Jackson MS; Kennedy H
Scand J Infect Dis; 2004; 36(4):259-63. PubMed ID: 15198181
[TBL] [Abstract][Full Text] [Related]
40. Genetic determinants and elements associated with antibiotic resistance in viridans group streptococci.
Brenciani A; Tiberi E; Tili E; Mingoia M; Palmieri C; Varaldo PE; Giovanetti E
J Antimicrob Chemother; 2014 May; 69(5):1197-204. PubMed ID: 24343896
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
